Tuis600196 • SHA
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
Vorige sluiting
¥28,74
Dagwisseling
¥28,08 - ¥29,05
Jaarwisseling
¥22,75 - ¥33,10
Markkapitalisasie
72,78 mjd CNY
Gemiddelde volume
46,09 m
P/V-verhouding
23,14
Dividend-opbrengs
1,14%
Primêre beurs
SHA
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 10,09 mjd | -2,05% |
Bedryfskoste | 4,19 mjd | 1,08% |
Netto inkomste | 937,21 m | 52,38% |
Netto winsgrens | 9,28 | 55,44% |
Wins per aandeel | — | — |
EBITDA | 1,38 mjd | -1,23% |
Effektiewe belastingkoers | 15,49% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,64 mjd | -2,87% |
Totale bates | 118,83 mjd | 2,85% |
Totale aanspreeklikheid | 58,51 mjd | 3,24% |
Totale ekwiteit | 60,32 mjd | — |
Uitstaande aandele | 2,64 mjd | — |
Prys om te bespreek | 1,60 | — |
Opbrengs op bates | 1,45% | — |
Opbrengs op kapitaal | 1,76% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 937,21 m | 52,38% |
Kontant van bedrywe | 1,08 mjd | 8,96% |
Kontant van beleggings | -674,65 m | 53,75% |
Kontant van finansiering | -826,57 m | -183,33% |
Netto kontantverandering | -422,05 m | -181,71% |
Beskikbare kontantvloei | 785,34 m | -53,00% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
40 234
